Tenpoint Therapeutics Secures FDA Approval for Presbyopia Eye Drops

Tenpoint Therapeutics, a biotechnology company developing treatments for impaired vision, announced FDA approval of Yuvezzi as a treatment for presbyopia on January 28th, 2026. The treatment, a prescription eye drop, is indicated for adults experiencing blurry close-up vision due to age. Tenpoint expects the treatment to be commercially available in Q2 2026. Yuvezzi is a […]

Pharmapack announces expansion to Asia with new event in Singapore, set for November 2026

Pharmapack, the leading European platform for pharmaceutical packaging and drug delivery innovation, today announced the launch of Pharmapack Asia, coming to Singapore in November 2026. The announcement was made by Sherma Ellis–Daal, Event Director at Pharmapack, during a keynote speech at the annual awards ceremony. “Singapore, renowned for its commitment to innovation and excellence, is […]

ACG Packaging Materials Launches SuperPodTM Setting a new benchmark for cold-form blister design

ACG Packaging Materials, which manufactures the world’s widest range of film and foil blister and lidding products, has launched its breakthrough cold-form blister technology, SuperPod™. Delivering meaningful advances in sustainability and efficiency, SuperPod™ enables blister cavities to become dramatically smaller – by up to 39 per cent in some cases while maintaining full barrier performance […]

Hovione’s people-first approach recognized as it achieves Top Employer certification for the fourth consecutive year

Hovione, an international integrated pharmaceutical development and manufacturing organization, has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year. A globally recognized certification, the Top Employers Institute acknowledges excellence in people practices. With over 2,500 employees globally in New Jersey (US), Cork (Ireland), Lisbon (Portugal), and Macau […]

Altegeon and GSK Subsidiary Enter Subcutaneous Formulation Technology Licensing Agreement

Altegeon, a biopharmaceutical company advancing novel biologics, announced an exclusive license agreement with Tesaro, a subsidiary of GSK, on January 20th, 2026. Per the terms of the agreement, Tesaro will acquire worldwide rights to use ALT-B4, Altegon’s novel hyaluronidase technology, for an upfront payment of $20 million and overall compensation totalling up to $265 million. […]

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning discovery (chemistry, biology, drug metabolism and pharmacokinetics), translational sciences, pharmaceutical development and manufacturing, clinical trials, […]